Insider plans sale of 66,783 shares of stock

Michael Terry Turner filed a notice to sell up to 66,783 shares of common stock through Raymond James & Associates on or after 08/14/2026, with an aggregate market value of $7,213,317.69.

Rhea-AI Filing Summary

Michael Terry Turner filed a notice to sell up to 66,783 shares of common stock through Raymond James & Associates on or after 08/14/2026, with an aggregate market value of $7,213,317.69. The issuer reports 151,112,640 shares outstanding. Shares to be sold come from a 401K purchase and restricted stock vesting. In the prior three months, Turner sold 53,601 shares for $5,794,100.00 and 2,737 shares for $296,500.00.

Key Figures

Shares to be sold: 66,783 shares Aggregate market value of planned sale: $7,213,317.69 Shares outstanding: 151,112,640 shares +5 more

8 metrics

Shares to be sold 66,783 shares Common stock planned for sale through Raymond James & Associates

Aggregate market value of planned sale $7,213,317.69 Value of 66,783 shares of common stock

Shares outstanding 151,112,640 shares Issuer’s common stock outstanding as reported

Recent sale 1 53,601 shares for $5,794,100.00 Common shares sold on 08/13/2026 by Michael Terry Turner

Recent sale 2 2,737 shares for $296,500.00 Common shares sold on 08/06/2026 by Michael Terry Turner

401K Purchase source shares 19,973 shares Common shares acquired via 401K Purchase on 04/30/2026

Restricted stock vesting 1 36,390 shares Common shares from restricted stock vesting on 12/26/2025

Restricted stock vesting 2 10,420 shares Common shares from restricted stock vesting on 01/01/2026

Key Terms

restricted stock vesting, 401K Purchase, aggregate market value, securities to be sold

4 terms

restricted stock vesting financial

"Common | 12/26/2025 | Restricted Stock Vesting | Issuer"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

401K Purchase financial

"Common | 04/30/2026 | 401K Purchase | Issuer"

aggregate market value financial

"66783 | 7213317.69 | 151112640 | 08/14/2026"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

securities to be sold regulatory

"144: Securities To Be Sold Common | 04/30/2026"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stock sale is disclosed for PNFP in this insider filing?

The filing shows Michael Terry Turner plans to sell up to 66,783 shares of common stock, with an aggregate market value of $7,213,317.69, through Raymond James & Associates on or after 08/14/2026.

How many PNFP shares has Michael Terry Turner sold in the last 3 months?

Over the past three months, Michael Terry Turner sold 53,601 shares for $5,794,100.00 and 2,737 shares for $296,500.00, according to the filing’s recent sales section.

What is the source of the PNFP shares Turner plans to sell?

The 66,783 shares planned for sale come from a 401K Purchase of 19,973 shares and restricted stock vesting of 36,390 and 10,420 shares, as itemized in the securities-to-be-sold section.

What is the reported market value of the PNFP shares to be sold?

The common shares to be sold by Michael Terry Turner have an aggregate market value of $7,213,317.69, as listed alongside the 66,783 shares of common stock in the securities information section.

How many PNFP shares are outstanding according to this filing?

The issuer’s common stock outstanding is reported as 151,112,640 shares. This figure appears in the issuer and securities information section and serves as context for the size of the planned sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/14/2026 - 05:22 PM EDT Accepted by SEC EDGAR 08/14/2026 - 05:20 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001248768
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Pinnacle Financial Partners, Inc.
SEC File Number	001-43038
Address of Issuer	3400 OVERTON PARK DR. SE ATLANTA FLORIDA 30339
Phone	(706) 641-6500
Name of Person for Whose Account the Securities are To Be Sold	TURNER M TERRY
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Raymond James & Associates, Inc. 880 Carillon Parkway St Petersburg FL 33716	66783	7213317.69	151112640	08/14/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	04/30/2026	401K Purchase	Issuer			19973	04/30/2026	401K Purchase
Common	12/26/2025	Restricted Stock Vesting	Issuer			36390	12/26/2025	Restricted Stock Vesting
Common	01/01/2026	Restricted Stock Vesting	Issuer			10420	01/01/2026	Restricted Stock Vesting

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Michael Terry Turner 10 Lynnwood Ln Nashville TN 37205	Common	08/13/2026	53601	5794100.00
Michael Terry Turner 10 Lynnwood Ln Nashville TN 37205	Common	08/06/2026	2737	296500.00

144: Remarks and Signature

Remarks
Date of Notice	08/14/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	05/07/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Tracey Cornelison, as duly authorized representative of Raymond James & Associates, Inc., as attorney-in-fact for M Terry Turner
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)